|
Table 3: Considerations for the individualization of high blood pressure treatment |
|
|
Situations |
Recommendations for antihypertensive treatment |
|
Heart failure with reduced LVEF |
ACEIs, ARBs, beta-blockers, thiazides, mineralocorticoid receptor inhibitor |
|
Ischemic heart disease |
ACEIs, ARBs, beta-blockers, mineralocorticoid receptor antagonist |
|
Chronic kidney disease |
ACEIs, ARBs |
|
Atrial fibrillation |
ACEIs, ARBs, and/or beta-blocker, non – dihydropyridine calcium antagonist |
|
Contraindications |
Antihypertensive drug |
|
Angioedema |
Avoid ACEIs |
|
Heart failure |
Avoid non – dihydropyridine calcium antagonists (E.g., verapamil, diltiazem) |
|
Pregnancy |
Avoid ACEIs, ARBs, or direct renin inhibitors |
|
AV conduction block or extreme bradycardia |
Do not use beta-blockers |